Loading company…
Syneos Health, Inc. provides integrated biopharmaceutical services spanning clinical development through commercial delivery for pharmaceutical companies.
Syneos Health, Inc., founded in 2017 and based in Morrisville, US, provides integrated biopharmaceutical solutions to mid-sized and large drug developers. Its most recent deal was a Public to Private, Secondary Buyout on May 9, 2023, in which Elliott Management, Patient Square Capital and Veritas Capital acquired a 90% majority stake for USD 4.46 bn, totaling USD 7.1 bn including outstanding debt. Alistair Macdonald serves as CEO, and the company reported revenue of USD 5,393.08 mn in 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in